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Divergent effects of estradiol and the estrogen receptor-alpha
agonist PPT on eating and activation of PVN CRH neurons in
ovariectomized rats and mice
Abstract
Eating is modulated by estradiol in females of many species and in women. To further investigate the
estrogen receptor mechanism mediating this effect, ovariectomized rats and mice were treated with
estradiol benzoate or the estrogen receptor-alpha (ER-alpha)-selective agonist PPT. PPT inhibited eating
in rats much more rapidly than estradiol (approximately 2-6 h versus >24 h). In contrast, the latencies to
vaginal estrus after PPT and estradiol were similar (>24 h). PPT also inhibited eating within a few hours
in wild-type mice, but failed to inhibit eating in transgenic mice deficient in ER-alpha (ERalphaKO
mice). PPT, but not estradiol, induced the expression of c-Fos in corticotrophin-releasing hormone
(CRH)-expressing cells of the paraventricular nucleus (PVN) of the hypothalamus within 90-180 min in
rats. Both PPT and estradiol reduced c-Fos expression in an ER-alpha-containing area of the nucleus of
the solitary tract. The anomalously rapid eating-inhibitory effect of PPT suggests that PPT's
neuropharmacological effect differs from estradiol's, perhaps because PPT differentially activates
membrane versus nuclear ER-alpha or because PPT activates non-ER-alpha membrane estrogen
receptors in addition to ER-alpha. The failure of PPT to inhibit eating in ERalphaKO mice, however,
indicates that ER-alpha is necessary for PPT's eating-inhibitory action and that any PPT-induced
activation of non-ER-alpha estrogen receptors is not sufficient to inhibit eating. Finally, the rapid
induction of c-Fos in CRH-expressing cells in the PVN by PPT suggests that PPT elicits a neural
response that is similar to that elicited by stress or aversive emotional stimuli.
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The role of hypoxia-inducible transcription factors
in the hypoxic neonatal brain
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Hypoxia-inducible transcription factors (HIF)-1 and HIF-2, composed of an oxygen-dependent a-subunit and a constitutive b-
subunit, have been characterized as the most important regulators of oxygen homeostasis during physiological and pathological
conditions. During embryonic, fetal and postnatal brain development, HIFs and speciﬁc HIF target genes are involved in early
and highly active maturational processes by modulating cell diﬀerentiation, vascular development, angiogenesis and metabolic
homeostasis. Under hypoxic conditions, activation of the HIF system reﬂects an immediate and cell-speciﬁc response to acute brain
hypoxia. In a complementary fashion, both HIF-1 and HIF-2 modulate cerebral hypoxic stress responses and activate endogenous
neuroprotective systems during acute and late stages of hypoxic/ischemic (HI) damage of the developing brain. Therefore, HIFs and
their speciﬁc target genes that are expressed during brain injury are of particular interest for future diagnostic and therapeutic
options in HI injury of the developing nervous system.
 2009 Elsevier B.V. All rights reserved.
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Hypoxic and ischemic complications during the pre-
and perinatal period are common causes of acquired
neonatal brain damage associated with severe long-term
neurodevelopmental disabilities. The broad spectrum of
risk factors includes acute hypoxic/ischemic (HI) injury
at birth arising from impaired materno-/feto-placental
blood ﬂow or acute anemia, as well as from chronically
compromised prenatal fetal oxygen and energy supply,
e.g. due to placental abnormalities or maternal diseases
[1]. Resulting patterns of HI brain injury are periventric-
ular lesions in the preterm newborn, and cortico-subcor-
tical lesions, especially in the senso-motor cortex and the0387-7604/$ - see front matter  2009 Elsevier B.V. All rights reserved.
doi:10.1016/j.braindev.2009.03.007
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(2009), doi:10.1016/j.braindev.2009.03.007parasagittal region, and deep gray matter lesions of
basal ganglia and thalamus in the near-term and term
newborn [2]. This selective vulnerability of the brain to
HI is mainly dictated by the stage of brain maturation
and severity of hypoxia [3]. Inﬂammatory (e.g. IL-6,
IL-1b, TNF-a), excitotoxic (e.g. glutamate, NMDA-R,
AMPA-R) and apoptotic pathways are involved in the
complex neurotoxic cascade following HI brain injury
[3] and activate a process of self-sustaining secondary
neurodegeneration in vulnerable CNS regions [4]. In
addition, the availability of endogenous adaptive mech-
anisms modifying early and delayed stages of hypoxia-
induced molecular cascade has been proposed as a cru-
cial factor in the pathophysiology of HI damage of the
developing brain. Among these adaptive systems,
hypoxia-inducible transcription factors (HIFs) are of
particular interest because of (a) their crucial adaptive
role during immediate cerebral response to HI, and (b)role of hypoxia-inducible transcription factors ..., Brain Dev
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tective mechanisms during late stages of HI damage of
the developing brain. These observations implicate HIFs
as diagnostic and therapeutic options in HI injury of the
developing nervous system.
2. Hypoxia-inducible transcription factors
Hypoxia-inducible transcription factors (HIF)-1 and
HIF-2 have been characterized as the most important
regulators of O2-dependent gene transcription modulat-
ing oxygen and metabolic supply during hypoxia. HIFs
are heterodimers of HIF-a (isoforms HIF-1a, HIF-2a,
HIF-3a) and HIF-b (also termed ARNT, aryl hydrocar-
bon receptor nuclear translocator) subunits that all
belong to the PAS family of basic helix–loop–helix
(bHLH) transcription factors. Under normoxic condi-
tions, HIF-a subunit is rapidly degraded by the ubiqui-
tin–proteasome pathway mediated by speciﬁc prolyl
residues. These residues are hydroxylated by HIF-prolyl
hydroxylases (prolyl hydroxylation domain protein
[PHD]), a process requiring di-oxygen and 2-oxoglutar-cofactors
HIF-1α
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Fig. 1. HIF-1 stabilization and activity under normoxia and hypoxia. Under
binding of HIF-1a to VHL followed by HIF-1a destruction via the ubiquitin/
dimerizes with the ubiquitously expressed HIF-1b subunit. Activation of
heterodimer to hypoxia response elements (HRE) of enhancers and promo
Lindau tumor suppressor protein; P, phosphorylated subunit.
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(2009), doi:10.1016/j.braindev.2009.03.007ate as co-substrates. Reduced activity of the PHDs
under hypoxia initiates stabilization of the HIF-a sub-
unit, heterodimerization with the b-subunit and activa-
tion of nuclear translocation that is followed by
binding of the HIF heterodimer to hypoxia response ele-
ments of enhancers and promoters of speciﬁc target
genes (Fig. 1). As a result, numerous HIF target genes
modify oxygen and energy supply, e.g. by activation of
glucose utilization (e.g. GLUT-1), vasoproliferative
and vasoactive eﬀects (e.g. vascular endothelial growth
factor, VEGF; inducible NO synthase, iNOS) and cell
survival (e.g. erythropoietin, EPO; insulin-like growth
factor-1, IGF-1) (for review, see [5]). Interestingly, spe-
ciﬁc hypoxia response elements have been identiﬁed in
the promoter region of HIF prolyl hydroxylases PHD2
and PHD3 inducing an autoregulatory feedback control
that may prevent overstimulation of the HIF system
during persisting hypoxia and reoxygenation [6]. The
most widely expressed a-subunit is HIF-1a that was
originally identiﬁed by aﬃnity puriﬁcation using oligo-
nucleotides from the EPO locus [7]. As shown by knock-
out studies [8], HIF-1a and HIF-2a (also known asH   Y   P   O   X   I   A 
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normoxic conditions, hydroxylation at speciﬁc proline residues leads to
proteasome pathway. During hypoxia, HIF-1a subunit is stabilized and
nuclear translocation is initiated followed by binding of the HIF-1
ters of speciﬁc target genes. OH, hydroxyl group; VHL, von Hippel-
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dant functions. Complementary action of the two a-sub-
units in the brain is further assumed e.g. by cell-type
speciﬁc regulation and diﬀerences in target gene speciﬁc-
ity [9–11]. For example, transcription of EPO during
cerebral hypoxia is mainly regulated by HIF-2a, but
not HIF-1a [9]. In contrast, transcriptional activity of
genes encoding for enzymes of glycolytic pathway is
under control of HIF-1a rather than HIF-2a [12].
Beside hypoxia, nitric oxide, metal ions (e.g. cobalt,
nickel) and iron chelators (e.g. desferrioxamine) induce
HIF-1a protein stabilization and transcriptional activity
at the level of PHDs even under normoxic conditions [5].
Carbon monoxide induces tissue hypoxygenation by
diminishing O2-carrying capacity inhibiting HIF-a pro-
tein degradation in vivo as shown in adult rodent brain
[11,13].
3. Role of HIFs during early brain development
During embryo- and organogenesis including brain
development physiological hypoxia stimulates vascular
development, angiogenesis and metabolic adaptation
controlled by the HIF regulatory cascade [14,15]. Dur-
ing normal mouse brain development, hypoxic regions
were detected from ED 8.5 to 9.0 in neuronal mesen-
chymal tissue associated with HIF-1a and VEGF co-
localization [14]. HIF-1a protein detectable in normox-
ic developing mouse brain at GD 20 [16] and P7 [17]
reﬂects persisting availability of HIF-1a in the regula-
tion of physiological oxygen demands during neonatal
period thereby ensuring fast and adequate adaptation
to physiological ﬂuctuations of cellular oxygen tension.
Moreover, the crucial role of HIFs and HIF target
genes for physiological vasculo- and angiogenesis and
brain development is emphasized by knockout experi-
ments. For example, HIF-1a knockout mouse embryos
exhibit defects in neural development such as open neu-
ral tubes and abnormal cephalic vascularisation and
lethality at ED 8.5 [8]. Embryonic brain defects in
EPO and EPO-R null mice (lethality at around ED
13.5) consist of a thinning of the neuroepithelium,
small brain size and incomplete closure of the neural
tube [18].
4. Activation of the HIF system in hypoxic developing
brain
Diﬀerent experimental neonatal rodent models of
hypoxic preconditioning [19,20], focal hypoxic/ische-
mic [19,21] and global non-ischemic hypoxic brain
injury [16,17] demonstrated up-regulation of cerebral
HIF proteins indicating their role in hypoxic stress-
induced molecular responses of the developing nervous
system. By establishing a mouse model of late-gestation
intrauterine hypoxia in mice our group investigatedPlease cite this article in press as: Trollmann R, Gassmann M. The
(2009), doi:10.1016/j.braindev.2009.03.007endogenous HIF regulation during acute hypoxia (6%
O2 for 6 h) in the very immature mouse brain at the last
day of mouse gestation (GD 20) [16] that approxi-
mately corresponds to the stage of brain maturation
of a preterm newborn at mid-gestation [22]. Regional
and cell-speciﬁc HIF-1a and HIF-2a protein accumula-
tion due to hypoxia in developing mouse brain (Fig. 2)
reﬂects immediate cerebral hypoxic stress responses in
selectively vulnerable regions to hypoxia such as cere-
bral cortex, hippocampus and subventricular zone [4].
Cell-type speciﬁc regulation of HIF responses to brain
hypoxia is evident from in vitro and in vivo studies,
however, in vivo HIF response to hypoxia of the devel-
oping brain has not being extensively studied. In adult
rodent brain, hypoxia induces stabilization and activity
of HIF-1a protein in neurons, astrocytes, ependymal
cells and endothelial cells [9,10,23], and HIF-2a protein
in astrocytes, endothelial cells and Purkinje cells of the
cerebellum [9,11]. Our studies performed at very early
stage of mouse brain maturation (GD 20; Fig. 2)
showed that HIF-1a is most prominently accumulated
in cortical neurons and, to a lower extent, in glial cells
and vascular endothelial cells of hippocampus and
periventricular zone upon exposure to systemic
hypoxia (6% O2, 6 h). In contrast to a report on P6
rat brains undergoing hypoxic preconditioning (8%
O2; 3 h) [20], we showed cerebral HIF-2a induction
upon exposure to hypoxia in the immature mouse
brains. This data suggest a diﬀerential sensitivity of
the HIF system that is attributable to developmental
stage, duration and severity of hypoxia as well as cell
type [9,12,20]. This is also the case for HIF target gene
activation. At early stage of brain development (GD
20), especially VEGF seems to belong to the group of
HIF target genes that are activated during early hyp-
oxic response of the developing brain in contrast to
EPO, GLUT-1 and iNOS [16,17]. Neuroprotective
eﬀects of VEGF have been shown in vitro and in vivo
in postnatal rodent brain in response to ischemia and
hypoxia [24,25]. VEGF is characterized as a neuronal
survival factor by mediating both auto- and paracrine
signaling functions in neurons in vitro [25] via its Flk-
1 receptor and phosphorylation of downstream signal-
ing molecules including MAPK, p90RSK, and STAT
family members. Astrocyte-derived VEGF mediates
survival and tube stabilization of hypoxic brain micro-
vascular endothelial cells in vitro [26]. Thus, immediate
induction of VEGF in developing hypoxic brain might
contribute to hypoxic tolerance of neurons and
astrocytes.
As to cell-speciﬁc target gene expression, in vitro
hypoxia (8% O2, 3 h) prominently induced e.g. VEGF,
prolyl-4-hydroxylase a and 12-lipoxygenase in primary
astrocytes rather than neurons, whereas adrenomedullin
was strongly up-regulated in neurons but not astrocytes
[20]. Of note, regulatory network mediating cerebralrole of hypoxia-inducible transcription factors ..., Brain Dev
Fig. 2. Immunohistochemistry for HIF-1a and HIF-2a in developing mouse brain (gestational day 20) exposed to acute systemic hypoxia (6% O2 for
6 h). (A) Coronal sections at the level of dorsal hippocampus are shown (A; left, overview; middle, hippocampus region, right, cerebral cortex; H.E.).
Co-staining for HIF-1a (B) with NeuN (C) and HIF-1a (D) with GFAP (E) demonstrates hypoxia-induced accumulation of HIF-1a in neurons of
the cerebral cortex, and, to a lower extent, in glial cells (note that scale bars in C and D are 5 lm). In contrast, HIF-2a (F) co-stained with GFAP (G)
was induced in glial cells of the hippocampus region (F and G) but not in neurons (data not shown). Adapted from Trollmann et al. [16].
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factors others than HIFs, such as NF-jB, EGF, insulin
signaling pathways and transcriptional regulators Myc,
Jun, and p53, modifying glucose metabolism, angiogenic
growth factors, cytokines as well as pro-apoptotic fac-
tors [12].Please cite this article in press as: Trollmann R, Gassmann M. The
(2009), doi:10.1016/j.braindev.2009.03.0075. HIFs as early markers of developing brain hypoxia
Prognostic markers which reliably identify neonates
for cerebral HI injury during the ﬁrst postnatal hours,
when neuroprotective therapies might be eﬃcient, are
limited [27]. As response of HIFs to changes in cellularrole of hypoxia-inducible transcription factors ..., Brain Dev
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Fig. 3. Western blot analysis of HIF-1a and HIF-2a protein in
developing mouse brain and placenta upon exposure of the pregnant
mother to normoxia (N) or hypoxia (H; 6% O2, 6 h) at GD 20. Both a-
subunits were detectable in normoxic brains (A and B) and placentas
(B). Of note, analysis of a hypoxic adult brain (A, lane 1) showed a less
intense HIF-1a band than a normoxic fetal brain (A, compare lanes 1
and 2). In response to acute hypoxia, HIF-1a and HIF-2a protein
stabilization is strongly induced in both developing brain and placenta.
Adapted from Trollmann et al. [16].
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promising markers to signal relevant tissue hypoxia.
Interestingly, human in vivo studies suggested adreno-
medullin and VEGF as early indicators of perinatal
brain injury in preterms [28] and term asphyxiated new-
borns [29,30]. Moreover, several HIF-regulated growth
factors measured in cord blood and placenta have been
identiﬁed to indicate acute or chronic perinatal hypoxia
in term newborns [31,32]. Based on existing cell biolog-
ical data elucidating molecular pathways involved in
the immediate responses of the developing brain to
hypoxia per se, and considering our mouse model of
acute antepartum systemic hypoxia [16] we propose
that HIFs and speciﬁc target genes represent indicators
of cerebral hypoxic distress during acute hypoxia. Spe-
ciﬁcally, systemic hypoxia at GD 20 induced a simulta-
neous up-regulation of HIF-1a and HIF-2a in
developing mouse brain and placenta implying that
placental accumulation of HIFs is indicative for fetal
cerebral hypoxic distress (Fig. 3). Of note, acute
hypoxia diﬀerentially aﬀected transcriptional activity
of speciﬁc HIF target genes in placenta and brain indi-
cating time- and cell-speciﬁc sensitivity of HIF target
genes to hypoxia [16] that might have future diagnostic
implications. Interestingly, experimental data sup-
ported previous observations of increased VEGF
expression in human placentas of asphyxiated new-
borns developing severe hypoxic–ischemic encephalop-
athy compared to controls [30].6. HIFs and neuroprotective strategies
Bergeron et al. [23] described protection of adult
rodent brain against experimental stroke by ‘‘hypoxic
preconditioning” which is deﬁned as exposure of
rodents to systemic non-lethal hypoxia (8% O2 forPlease cite this article in press as: Trollmann R, Gassmann M. The
(2009), doi:10.1016/j.braindev.2009.03.0073 h) before the ischemic event. This ‘‘ischemic toler-
ance” similarly observed due to preconditioning by
desferrioxamine and cobalt chloride in adult brain
[23] and retina [33] as well as in neonatal rodent brain
[19] has been proposed to be the result of HIF-1 and
HIF target gene activation (e.g. VEGF, EPO, adreno-
medullin). Among these protective target genes, espe-
cially EPO has been extensively investigated in terms
of its therapeutic use to reduce stroke volume and
improve functional outcome after neonatal stroke in
rodents. Neuroprotection by recombinant EPO (rEPO)
includes many pathways such as diminishing apoptosis
by activation of anti-apoptotic proteins bcl-2 and bcl-
XL and inhibition of pro-apoptotic caspases, inﬂam-
mation, excitotoxicity and activation of brain derived
neurotrophic factor [34,35]. Moreover, processes of
late brain recovery after HI injury are modulated by
EPO such as neurogenesis, angiogenesis and migration
of regenerating neurons (for review, see [36]). Protec-
tive eﬀects have even been found if high-dose rEPO
treatment was initiated after the onset of HI injury in
neonatal rodents [34]. Human data on neuroprotective
eﬀects of rEPO in hypoxic neonatal brain injury is lim-
ited. Studies initiated for treatment of anemia showed
no signiﬁcant improvement of neurodevelopmental
outcome in preterm neonates who received low-dose
rEPO [37]. A recent randomized mono-center study
on eﬃcacy and safety of high-dose rEPO treatment in
premature infants revealed no signiﬁcant eﬀects on
short-term outcome, however, of importance, no sig-
niﬁcant adverse eﬀects [38]. Neurobiological character-
istics of EPO/EPO-R system during development
might explain diﬀerences of in vitro and in vivo eﬀects
such as limited transport across blood–brain-barrier
and delayed hypoxia-induced activation of the hetero-
dimeric low aﬃnity EPO-R [36].
The hypothesis arises as whether it is advantageous to
target HIFs for neuroprotection as activation of the
broad spectrum of HIF target genes might have syner-
gistic protective eﬀects. Indeed, embryonic neuronal cell
culture experiments [39] showed that inhibitors of PHD
signiﬁcantly prevented glutamate-induced neuronal
death suggesting PHD as promising targets for protec-
tion from oxidative death in neurons.
In summary, at early developmental stage of brain
maturation, HIFs well characterized as complementary
systems to modulate hypoxic stress responses reﬂect an
immediate and cell-speciﬁc response to acute brain
hypoxia. Based on experimental data, HIFs and HIF
target genes are promising candidates for potential
future diagnostic and prognostic marker systems in peri-
natal HI encephalopathy. Addressing both cellular and
regional vulnerability of the developing brain pharma-
cological activation of HIF-regulated mechanisms might
reﬂect targets for future studies on age-appropriate neu-
roprotection in newborns.role of hypoxia-inducible transcription factors ..., Brain Dev
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